top of page
Progress
2022
Patented novel material methods for the surface modification of implants
2023
Innosuisse grant for feasibility studies relative to commercial control $500k+
2023
COSKIN percutaneous implants prevent recurring injury in chronic animal trials (PoC I)
2024
COSKIN percutaneous cables reduce infection in chronic animal trials (PoC II)
May 2024
Attended Swiss Startup and Swiss Medtech days, Bern
June 2024
KOLs and investor meetings with AIT Mexico and Venture Labs in Mexico & China
August 2024
New patent priority granted to enable energy and data transfer with small, ultra-flexible wires
January 2025
Prove feasibility for safe energy & data transfer with small ultra-flexible wires in human relevant animal models
June 2025
Our technical report comparing our technology with HM3 drivelines is available for review
News
News & Progress
bottom of page